News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
WAN MARK A
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2020 |
4
| WAN MARK A (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns:
| Granted 7,500 shares
@ $0 Granted 15,000 options to buy
@ $1.43, valued at
$21.5k
|
|
06/25/2019 |
4
| WAN MARK A (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns:
| Granted 3,750 shares
@ $0 Granted 7,500 options to buy
@ $2.19, valued at
$16.4k
|
|
06/14/2018 |
4
| WAN MARK A (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns:
| Granted 15,000 options to buy
@ $4.125, valued at
$61.9k
|
|
05/23/2018 |
4
| WAN MARK A (10% Owner) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns:
| Disposed of 3,347,357 shares
@ $0 Disposed of 179,962 shares
@ $0 Disposed of 5,713,569 shares
@ $0 Disposed of 126,153 shares
@ $0 |
|
06/15/2017 |
4
| WAN MARK A (10% Owner) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns:
| Granted 15,000 options to buy
@ $2.3, valued at
$34.5k
|
|
06/22/2016 |
4
| WAN MARK A (10% Owner) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns:
| Granted 15,000 options to buy
@ $2.87, valued at
$43.1k
|
|
06/24/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/20/2014 |
4
| Three Arch Management IV, L.L.C. (10% Owner) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Sold 244,600 shares
@ $12.29, valued at
$3M
Sold 5,400 shares
@ $12.29, valued at
$66.4k
|
|
11/20/2014 |
4
| THREE ARCH MANAGEMENT III LLC (10% Owner) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Sold 237,245 shares
@ $12.29, valued at
$2.9M
Sold 12,755 shares
@ $12.29, valued at
$156.8k
|
|
11/12/2014 |
4
| Three Arch Management IV, L.L.C. (Former 10% Beneficial Owner) has filed a Form 4 on NEVRO CORP
Txns:
| Converted 1,272,187 shares
@ $0 Converted 682,475 shares
@ $0 Converted 204,076 shares
@ $0 Converted 28,090 shares
@ $0 Converted 15,069 shares
@ $0 Converted 4,506 shares
@ $0 Converted 1,272,187 preferred shares
@ $0 Converted 682,475 preferred shares
@ $0 Converted 204,076 preferred shares
@ $0 Converted 28,090 preferred shares
@ $0 Converted 15,069 preferred shares
@ $0 |
|
07/25/2014 |
4
| WAN MARK A (10% Owner) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns:
| Granted 15,000 options to buy
@ $10.22, valued at
$153.3k
|
|
03/11/2014 |
4
| WAN MARK A (10% Owner) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns:
| Sold 46,661 shares
@ $12.3882, valued at
$578k
Sold 12,186 shares
@ $11.96, valued at
$145.7k
Sold 298,508 shares
@ $12.36, valued at
$3.7M
Sold 2,508 shares
@ $12.3882, valued at
$31.1k
Sold 655 shares
@ $11.96, valued at
$7.8k
Sold 16,049 shares
@ $12.36, valued at
$198.4k
Sold 79,645 shares
@ $12.3882, valued at
$986.7k
Sold 20,800 shares
@ $11.96, valued at
$248.8k
Sold 509,520 shares
@ $12.36, valued at
$6.3M
Sold 1,759 shares
@ $12.3882, valued at
$21.8k
Sold 459 shares
@ $11.96, valued at
$5.5k
|
|
02/21/2014 |
4
| Three Arch Management IV, L.L.C. (10% Owner) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Converted 5,735 shares
@ $0 Converted 7,647 shares
@ $0 Converted 1,529 shares
@ $0 Converted 259,751 shares
@ $0 Converted 346,335 shares
@ $0 Converted 69,267 shares
@ $0 Bought 2,236 shares
@ $14, valued at
$31.3k
Bought 101,264 shares
@ $14, valued at
$1.4M
Converted 32,405 convertible preferred
@ $0 Converted 43,206 convertible preferred
@ $0 Converted 8,641 convertible preferred
@ $0 |
|
02/21/2014 |
4
| THREE ARCH MANAGEMENT III LLC (10% Owner) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Converted 13,545 shares
@ $0 Converted 18,060 shares
@ $0 Converted 3,612 shares
@ $0 Converted 251,941 shares
@ $0 Converted 335,922 shares
@ $0 Converted 67,184 shares
@ $0 Bought 5,281 shares
@ $14, valued at
$73.9k
Bought 98,219 shares
@ $14, valued at
$1.4M
Converted 76,531 convertible preferred
@ $0 Converted 102,041 convertible preferred
@ $0 Converted 20,408 convertible preferred
@ $0 |
|
09/13/2013 |
4
| WAN MARK A (10% Owner) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns:
| Granted 15,000 options to buy
@ $10.55, valued at
$158.3k
|
|
03/13/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/11/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/14/2012 |
4
| WAN MARK A (Director) has filed a Form 4 on EPOCRATES INC
Txns:
| Granted 11,790 options to buy
@ $8.14, valued at
$96k
|
|
07/26/2012 |
4
| WAN MARK A (10% Owner) has filed a Form 4 on ACELRX PHARMACEUTICALS INC |
05/10/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/18/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/18/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/18/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/18/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/07/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/07/2011 |
4
| WAN MARK A (Director) has filed a Form 4 on EPOCRATES INC
Txns:
| Converted 1,018,165 shares
@ $0 Converted 348,001 shares
@ $0 Converted 581,279 shares
@ $0 Sold 292,116 shares
@ $16, valued at
$4.7M
Converted 1,295,376 convertible preferred
@ $0 Converted 383,205 convertible preferred
@ $0 Converted 739,541 convertible preferred
@ $0 |
|
|
|